pharmacie et médicaments – Conséquences de la DERU sur le prix des médicaments génériques

This written question asks about the consequences of the DERU (Drug Ex-Factory Remuneration) on the pricing of generic medicines in France. It seeks to understand how this pricing mechanism affects the availability and affordability of essential drugs. The question is posed by a French National Assembly member, indicating a focus on national policy and its impact on patients, pharmaceutical companies, and the healthcare system within France.